The Hikma Court correctly held that a generic manufacturer should not be liable for induced patent infringement if it carves ...
On June 16, 2026, the Centers for Medicare & Medicaid Services (CMS) published a proposed rule that would codify the Medicare Drug Price ...
It’s time to bring production of essential medications back to the U.S. — or at least closer to home. The meeting, described ...
FDA accepts two applications for generic weight loss drugs amid international competition as well as issues of patents and ...
Federal regulators have agreed to review a Swiss pharmaceutical company's applications for two cheaper generic versions of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results